After analyzing the clinical samples of human bladder cancer, we found that the expression of FATP2 in cancer stages III and IV was higher than that in stages I and II,and the expression of RIPK3 in cancer stages III and IV was lower than that in stages I and II. This evidence concerns the gene SLC27A2 and cancer.